COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan

Abstract The immunity of patients who recover from coronavirus disease 2019 (COVID-19) could be long lasting but persist at a lower level. Thus, recovered patients still need to be vaccinated to prevent reinfection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or its mutated varian...

Full description

Bibliographic Details
Main Authors: Hong Liang, Xuanxuan Nian, Junzheng Wu, Dong Liu, Lu Feng, Jia Lu, Yan Peng, Zhijun Zhou, Tao Deng, Jing Liu, Deming Ji, Ran Qiu, Lianzhen Lin, Yan Zeng, Fei Xia, Yong Hu, Taojing Li, Kai Duan, Xinguo Li, Zejun Wang, Yong Zhang, Hang Zhang, Chen Zhu, Shang Wang, Xiao Wu, Xiang Wang, Yuwei Li, Shihe Huang, Min Mao, Huanhuan Guo, Yunkai Yang, Rui Jia, Jingwei Xufang, Xuewei Wang, Shuyan Liang, Zhixin Qiu, Juan Zhang, Yaling Ding, Chunyan Li, Jin Zhang, Daoxing Fu, Yanlin He, Dongbo Zhou, Cesheng Li, Jiayou Zhang, Ding Yu, Xiao-Ming Yang
Format: Article
Language:English
Published: Nature Publishing Group 2022-12-01
Series:Cell Discovery
Online Access:https://doi.org/10.1038/s41421-022-00496-x
_version_ 1828121199249457152
author Hong Liang
Xuanxuan Nian
Junzheng Wu
Dong Liu
Lu Feng
Jia Lu
Yan Peng
Zhijun Zhou
Tao Deng
Jing Liu
Deming Ji
Ran Qiu
Lianzhen Lin
Yan Zeng
Fei Xia
Yong Hu
Taojing Li
Kai Duan
Xinguo Li
Zejun Wang
Yong Zhang
Hang Zhang
Chen Zhu
Shang Wang
Xiao Wu
Xiang Wang
Yuwei Li
Shihe Huang
Min Mao
Huanhuan Guo
Yunkai Yang
Rui Jia
Jingwei Xufang
Xuewei Wang
Shuyan Liang
Zhixin Qiu
Juan Zhang
Yaling Ding
Chunyan Li
Jin Zhang
Daoxing Fu
Yanlin He
Dongbo Zhou
Cesheng Li
Jiayou Zhang
Ding Yu
Xiao-Ming Yang
author_facet Hong Liang
Xuanxuan Nian
Junzheng Wu
Dong Liu
Lu Feng
Jia Lu
Yan Peng
Zhijun Zhou
Tao Deng
Jing Liu
Deming Ji
Ran Qiu
Lianzhen Lin
Yan Zeng
Fei Xia
Yong Hu
Taojing Li
Kai Duan
Xinguo Li
Zejun Wang
Yong Zhang
Hang Zhang
Chen Zhu
Shang Wang
Xiao Wu
Xiang Wang
Yuwei Li
Shihe Huang
Min Mao
Huanhuan Guo
Yunkai Yang
Rui Jia
Jingwei Xufang
Xuewei Wang
Shuyan Liang
Zhixin Qiu
Juan Zhang
Yaling Ding
Chunyan Li
Jin Zhang
Daoxing Fu
Yanlin He
Dongbo Zhou
Cesheng Li
Jiayou Zhang
Ding Yu
Xiao-Ming Yang
author_sort Hong Liang
collection DOAJ
description Abstract The immunity of patients who recover from coronavirus disease 2019 (COVID-19) could be long lasting but persist at a lower level. Thus, recovered patients still need to be vaccinated to prevent reinfection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or its mutated variants. Here, we report that the inactivated COVID-19 vaccine can stimulate immunity in recovered patients to maintain high levels of anti-receptor-binding domain (RBD) and anti-nucleocapsid protein (NP) antibody titers within 9 months, and high neutralizing activity against the prototype, Delta, and Omicron strains was observed. Nevertheless, the antibody response decreased over time, and the Omicron variant exhibited more pronounced resistance to neutralization than the prototype and Delta strains. Moreover, the intensity of the SARS-CoV-2-specific CD4+ T cell response was also increased in recovered patients who received COVID-19 vaccines. Overall, the repeated antigen exposure provided by inactivated COVID-19 vaccination greatly boosted both the potency and breadth of the humoral and cellular immune responses against SARS-CoV-2, effectively protecting recovered individuals from reinfection by circulating SARS-CoV-2 and its variants.
first_indexed 2024-04-11T14:16:58Z
format Article
id doaj.art-e71bae845a314b169b4bf8300c2580e3
institution Directory Open Access Journal
issn 2056-5968
language English
last_indexed 2024-04-11T14:16:58Z
publishDate 2022-12-01
publisher Nature Publishing Group
record_format Article
series Cell Discovery
spelling doaj.art-e71bae845a314b169b4bf8300c2580e32022-12-22T04:19:23ZengNature Publishing GroupCell Discovery2056-59682022-12-018111410.1038/s41421-022-00496-xCOVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in WuhanHong Liang0Xuanxuan Nian1Junzheng Wu2Dong Liu3Lu Feng4Jia Lu5Yan Peng6Zhijun Zhou7Tao Deng8Jing Liu9Deming Ji10Ran Qiu11Lianzhen Lin12Yan Zeng13Fei Xia14Yong Hu15Taojing Li16Kai Duan17Xinguo Li18Zejun Wang19Yong Zhang20Hang Zhang21Chen Zhu22Shang Wang23Xiao Wu24Xiang Wang25Yuwei Li26Shihe Huang27Min Mao28Huanhuan Guo29Yunkai Yang30Rui Jia31Jingwei Xufang32Xuewei Wang33Shuyan Liang34Zhixin Qiu35Juan Zhang36Yaling Ding37Chunyan Li38Jin Zhang39Daoxing Fu40Yanlin He41Dongbo Zhou42Cesheng Li43Jiayou Zhang44Ding Yu45Xiao-Ming Yang46Beijing Tiantan Biological Products Co., Ltd.National Engineering Technology Research Center for Combined VaccinesChengdu Rongsheng Pharmaceuticals Co., Ltd.Beijing Tiantan Biological Products Co., Ltd.Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.National Engineering Technology Research Center for Combined VaccinesSinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.National Engineering Technology Research Center for Combined VaccinesNational Engineering Technology Research Center for Combined VaccinesSinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.National Engineering Technology Research Center for Combined VaccinesSinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.National Engineering Technology Research Center for Combined VaccinesNational Engineering Technology Research Center for Combined VaccinesSinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.Beijing Tiantan Biological Products Co., Ltd.National Engineering Technology Research Center for Combined VaccinesNational Engineering Technology Research Center for Combined VaccinesNational Engineering Technology Research Center for Combined VaccinesBeijing Tiantan Biological Products Co., Ltd.Beijing Tiantan Biological Products Co., Ltd.Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.National Engineering Technology Research Center for Combined VaccinesNational Engineering Technology Research Center for Combined VaccinesNational Engineering Technology Research Center for Combined VaccinesSinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.Wuxue Wusheng Plasma Collection CenterChina National Biotec Group Company LimitedChina National Biotec Group Company LimitedChina National Biotec Group Company LimitedChina National Biotec Group Company LimitedWuhan Biobank Co., Ltd.Wuhan Biobank Co., Ltd.Wuhan Biobank Co., Ltd.Chengdu Rongsheng Pharmaceuticals Co., Ltd.Beijing Tiantan Biological Products Co., Ltd.Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.Beijing Tiantan Biological Products Co., Ltd.Beijing Tiantan Biological Products Co., Ltd.Beijing Tiantan Biological Products Co., Ltd.Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.National Engineering Technology Research Center for Combined VaccinesBeijing Tiantan Biological Products Co., Ltd.National Engineering Technology Research Center for Combined VaccinesAbstract The immunity of patients who recover from coronavirus disease 2019 (COVID-19) could be long lasting but persist at a lower level. Thus, recovered patients still need to be vaccinated to prevent reinfection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or its mutated variants. Here, we report that the inactivated COVID-19 vaccine can stimulate immunity in recovered patients to maintain high levels of anti-receptor-binding domain (RBD) and anti-nucleocapsid protein (NP) antibody titers within 9 months, and high neutralizing activity against the prototype, Delta, and Omicron strains was observed. Nevertheless, the antibody response decreased over time, and the Omicron variant exhibited more pronounced resistance to neutralization than the prototype and Delta strains. Moreover, the intensity of the SARS-CoV-2-specific CD4+ T cell response was also increased in recovered patients who received COVID-19 vaccines. Overall, the repeated antigen exposure provided by inactivated COVID-19 vaccination greatly boosted both the potency and breadth of the humoral and cellular immune responses against SARS-CoV-2, effectively protecting recovered individuals from reinfection by circulating SARS-CoV-2 and its variants.https://doi.org/10.1038/s41421-022-00496-x
spellingShingle Hong Liang
Xuanxuan Nian
Junzheng Wu
Dong Liu
Lu Feng
Jia Lu
Yan Peng
Zhijun Zhou
Tao Deng
Jing Liu
Deming Ji
Ran Qiu
Lianzhen Lin
Yan Zeng
Fei Xia
Yong Hu
Taojing Li
Kai Duan
Xinguo Li
Zejun Wang
Yong Zhang
Hang Zhang
Chen Zhu
Shang Wang
Xiao Wu
Xiang Wang
Yuwei Li
Shihe Huang
Min Mao
Huanhuan Guo
Yunkai Yang
Rui Jia
Jingwei Xufang
Xuewei Wang
Shuyan Liang
Zhixin Qiu
Juan Zhang
Yaling Ding
Chunyan Li
Jin Zhang
Daoxing Fu
Yanlin He
Dongbo Zhou
Cesheng Li
Jiayou Zhang
Ding Yu
Xiao-Ming Yang
COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan
Cell Discovery
title COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan
title_full COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan
title_fullStr COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan
title_full_unstemmed COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan
title_short COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan
title_sort covid 19 vaccination boosts the potency and breadth of the immune response against sars cov 2 among recovered patients in wuhan
url https://doi.org/10.1038/s41421-022-00496-x
work_keys_str_mv AT hongliang covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT xuanxuannian covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT junzhengwu covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT dongliu covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT lufeng covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT jialu covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT yanpeng covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT zhijunzhou covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT taodeng covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT jingliu covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT demingji covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT ranqiu covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT lianzhenlin covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT yanzeng covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT feixia covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT yonghu covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT taojingli covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT kaiduan covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT xinguoli covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT zejunwang covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT yongzhang covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT hangzhang covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT chenzhu covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT shangwang covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT xiaowu covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT xiangwang covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT yuweili covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT shihehuang covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT minmao covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT huanhuanguo covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT yunkaiyang covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT ruijia covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT jingweixufang covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT xueweiwang covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT shuyanliang covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT zhixinqiu covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT juanzhang covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT yalingding covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT chunyanli covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT jinzhang covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT daoxingfu covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT yanlinhe covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT dongbozhou covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT ceshengli covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT jiayouzhang covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT dingyu covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan
AT xiaomingyang covid19vaccinationbooststhepotencyandbreadthoftheimmuneresponseagainstsarscov2amongrecoveredpatientsinwuhan